November 07, 2023
A California federal judge has granted final approval to a $13 million settlement between investors and biotechnology company Precigen Inc. over claims it misrepresented aspects of a program aimed at converting methane into more valuable products.
March 03, 2023
Investors asked a California federal judge Thursday to approve a $13 million settlement they have reached with biotechnology company Precigen Inc. over claims that the company misrepresented aspects of a program aimed at converting methane into more valuable products.
June 01, 2022
A California federal judge has tossed a proposed investor class action alleging biotechnology company Precigen Inc. misrepresented aspects of a program aimed at converting methane into more valuable chemicals, but gave the proposed class leave to amend its claims.
April 08, 2021
A federal judge in San Jose, California, on Thursday appointed Scott + Scott Attorneys at Law LLP to represent a proposed class of investors in biotechnology company Precigen Inc. in a suit alleging the company misrepresented aspects of a program aimed at converting methane into more valuable chemicals.